Intersect ENT
XENT
#6113
Rank
ยฃ0.69 B
Marketcap
ยฃ20.45
Share price
0.00%
Change (1 day)
6.19%
Change (1 year)

Revenue for Intersect ENT (XENT)

Revenue in 2021: ยฃ77.31 Million

According to Intersect ENT's latest financial reports the company's current revenue (TTM ) is ยฃ77.31 Million. In 2021 the company made a revenue of ยฃ77.31 Million an increase over the revenue in the year 2020 that were of ยฃ58.33 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intersect ENT from 2012 to 2021

Annual revenue

Year Revenue Change
2021ยฃ77.31 M32.52%
2020ยฃ58.33 M-26.19%
2019ยฃ79.04 M0.62%
2018ยฃ78.55 M12.64%
2017ยฃ69.74 M22.35%
2016ยฃ57 M27.79%
2015ยฃ44.6 M59.62%
2014ยฃ27.94 M115.2%
2013ยฃ12.98 M205.83%
2012ยฃ4.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Ocular Therapeutix
OCUL
ยฃ40.39 M-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ICON plc
ICLR
ยฃ5.86 B 7,490.40%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Anika Therapeutics
ANIK
ยฃ58.6 M-24.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
ยฃ0.96 B 1,143.91%๐Ÿ‡บ๐Ÿ‡ธ USA